NEXT

Charles Toutant

Charles Toutant

Charles Toutant is a litigation writer for the New Jersey Law Journal.

Connect with this author

October 24, 2007 | New Jersey Law Journal

Parent Who Did Not Support a Child Can Share in Her Estate, Court Says

A parent need not have supported a child to qualify as a parent for purposes of intestate inheritance upon the child's death, a New Jersey appeals court says.

By Charles Toutant

4 minute read

July 22, 2002 | New Jersey Law Journal

Pros and Cons of Capping Managing Partners' Terms

As firms grow and diversity, new management practices are catching on, among them the placing of term limits on managing partners. Advocates of the practice say it ensures an influx of new ideas, guards against generational conflict within the firm and promotes smoother leadership successions.

By Charles Toutant

6 minute read

August 29, 2005 | New Jersey Law Journal

A Shallower Gender Pool

There are proportionally fewer women in the associate ranks at New Jersey's largest firms this year, and no one seems to know quite why. While the overall associate population increased slightly at the firms studied in the Law Journal's annual census of women and ethnic lawyers, the number of women associates declined. At 19 firms surveyed, women made up 37.4 percent of all associates in 2005, down from 41.9 percent last year.

By Charles Toutant

7 minute read

August 05, 2009 | New Jersey Law Journal

No Affidavit of Merit or Expert Needed To Sue One's Lawyer for Fraud

Noncompliance with the affidavit of merit statute in a legal malpractice suit does not preclude a plaintiff from bringing a common-law fraud case against her lawyer, a state appeals court ruled on Tuesday.

By Charles Toutant

4 minute read

November 13, 2001 | Law.com

Seton Hall Fire Victims' Lawyers Still Scrambling to Identify Defendants

With the two-year statute of limitations almost up, lawyers representing victims of the Seton Hall University dormitory fire are working frantically to find parties to sue. The fire, which authorities believe was intentionally started, broke out in the Boland Hall dormitory on Jan. 19, 2000, killing three students and injuring 58 others.

By Charles Toutant

3 minute read

August 01, 2006 | National Law Journal

Gibbons Del Deo Boosting Salaries for First-Year Associates to $120,000

Though the dust has scarcely settled in this year's law-firm salary derby, the 2007 race is already heating up. Gibbons, Del Deo, Dolan, Griffinger & Vecchione is raising its first-year associate salaries to $120,000, effective Jan. 1, at its Newark, N.J., and New York offices. That's a 23 percent jump from the 2006 rate of $97,000. Gibbons Del Deo's action comes a month after Roseland, N.J.'s Lowenstein Sandler announced plans to hike first-year associate compensation to $125,000 on Jan. 1.

By Charles Toutant

3 minute read

December 10, 2009 | New Jersey Law Journal

Municipal Judge Is Charged With Misuse of Office

An ethics complaint made public on Thursday alleges that Phillipsburg Municipal Judge Dennis Baptista used the power of his office to gain an advantage in a private dispute with another parent over damage to his son's car.

By Charles Toutant

5 minute read

April 21, 2010 | New Jersey Law Journal

Court Revives Legal Malpractice Suit Over a Judge's Pre-Bench Lawyering

Superior Court Judge Mary Thurber will have to answer for alleged malpractice and excessiveness of fees charged as a lawyer, now that a suit by her former clients has been reinstated.

By Charles Toutant

6 minute read

February 19, 2009 | New Jersey Law Journal

UM Coverage Held Not Applicable in Drive-by Shootings

Uninsured motorist coverage does not extend to a victim of a random, drive-by shooting, even though PIP coverage does, a sharply divided N.J. Supreme Court rules.

By Charles Toutant

3 minute read

December 26, 2006 | The Legal Intelligencer

Plavix Makers Sued For Ignoring Drug's Health Risks

Plavix, a popular blood-thinning drug, is the target of multiple lawsuits by users and third-party payers, who charge that manufacturers Bristol-Myers Squibb and Sanofi-Aventis US marketed the drug in disregard of its potential health risks.

By Charles Toutant ALM

4 minute read